Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-029915
Filing Date
2023-08-23
Accepted
2023-08-23 12:16:55
Documents
44
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1007708
2 ex31.htm EX-31 11860
3 ex32.htm EX-32 4021
  Complete submission text file 0001493152-23-029915.txt   4094451

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE clcs-20230331.xsd EX-101.SCH 25716
5 XBRL CALCULATION FILE clcs-20230331_cal.xml EX-101.CAL 32638
6 XBRL DEFINITION FILE clcs-20230331_def.xml EX-101.DEF 174755
7 XBRL LABEL FILE clcs-20230331_lab.xml EX-101.LAB 241572
8 XBRL PRESENTATION FILE clcs-20230331_pre.xml EX-101.PRE 214842
38 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 514333
Mailing Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019
Business Address 57 WEST 57TH STREET SUITE 400 NEW YORK NY 10019 646-612-7554
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 231196164
SIC: 2834 Pharmaceutical Preparations